0001493152-23-022059.txt : 20230621 0001493152-23-022059.hdr.sgml : 20230621 20230621195843 ACCESSION NUMBER: 0001493152-23-022059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230616 FILED AS OF DATE: 20230621 DATE AS OF CHANGE: 20230621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASAMENTO CHARLES J CENTRAL INDEX KEY: 0001117167 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40023 FILM NUMBER: 231031250 MAIL ADDRESS: STREET 1: 99 BELBROOK WAY CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: SUITE 100 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: SUITE 100 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 ownership.xml X0407 4 2023-06-16 0 0000109657 GT Biopharma, Inc. GTBP 0001117167 CASAMENTO CHARLES J C/O GT BIOPHARMA, INC. 8000 MARINA BLVD., STE. 100 BRISBANE CA 94005 1 0 0 0 0 Option to purchase Common Stock 0.35 2023-06-16 4 A 0 500000 0 A 2033-06-15 Common Stock 500000 500000 D 1/12th of the shares vest on the monthly anniversary of May 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct. /s/ Charles J. Casamento 2023-06-21